Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients

Stroke

Volumn 34, Issue 5, 2003, Pages 1235-1240

  Alvarez Sabín, José ^a   Molina, Carlos A ^b   Montaner, Joan ^b   Arenillas, Juan F ^b   Huertas, Rafael ^b   Ribo, Marc ^b   Codina, Agusti ^b   Quintana, Manuel ^b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b NONE

Author keywords

Disease progression; Hyperglycemia; Outcome; Thrombolysis; Ultrasonography

Indexed keywords

GLUCOSE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGE; AGED; ARTICLE; BRAIN BLOOD FLOW; CEREBRAL ARTERY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DOPPLER FLOWMETRY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; PRIORITY JOURNAL; RECANALIZATION; REPERFUSION; STROKE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CEREBRAL HEMORRHAGE; COMORBIDITY; DIABETES MELLITUS; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPERTENSION; INFARCTION, MIDDLE CEREBRAL ARTERY; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; OXIDATIVE STRESS; RECOMBINANT PROTEINS; RECURRENCE; REPERFUSION; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 0037967223     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000068406.30514.31     Document Type: Article

References (35)

1. Toni D, Sacchetti ML, Argentino C, Gentile M, Cavalletti C, Frontoni M, Fieschi C. Does hyperglycemia play a role in outcome of acute ischaemic stroke patients? J Neurol. 1992;239:382-386.
2. van Kooten F, Hoogerbrugge N, Naarding P, Kandstaal PJ. Hyperglycemia in the acute phase is not caused by stress. Stroke. 1993;24:1129-1132.
3. Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke. 1989;19:547-554.
4. Bruno A, Biller J, Adams HP Jr, Clarke WR, Woolson RF, Williams LS, Hansen MD, for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Acute blood glucose level and outcome from ischemic stoke. Neurology. 1999;52:280-284.
5. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study. BMJ. 1997;314:1303-1306.
6. Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, Lyden PD, Broderick JP, Kwiatkowski TG, Fineberg SE, and the NINDS rt-PA Stroke Study Group. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology. 2002;59:669-674.
7. Prado R, Ginsberg MD, Dietrich WD, Watson BD, Busto R. Hyperglycemia increases infarct size in collaterally perfused but not end-arterial vascular territories. J Cereb Blood Flow Metab. 1988;8:186-192.
8. de Courten-Myers GM, Kleinholz M, Wagner KR, Myers RE. Normoglycemia (not hypoglycemia) optimizes outcome from middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1994;14:227-236.
9. Kraft SA, Larson CPJ, Shuer LM, Steinberg GK, Benson GV, Pearl RG. Effect of hyperglycemia on neuronal changes in a rabbit model of focal cerebral ischemia. Stroke. 1990;21:447-450.
10. 3H] nimodipine in focal cerebral ischemia: modulation by hyperglycemia. J Cereb Blood Flow Metab. 1997;17:1057-1065.
11. The National Institutes of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
12. Demchuk AM, Morgenstern LB, Krieger DW, Chi TL, Hu W, Wein TH, Hardy RJ, Grotta JC, Buchan AM. Serum glucose and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke. 1999;30:34-39.
13. Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, Levine SR, and the Multicenter rt-PA Stroke Survey Group. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Acute Stroke Survey. Circulation. 2002;105:1679-1685.
14. Hacke W, Kaste M, Skyhoj Olsen T, Orgogozo JM, Bogousslavsky J, for the European Stroke Initiative Writing Committee. European Stroke Initiative (EUSI) recommendations for stroke management. Eur J Neurol. 2000;7:607-623.
15. Zanette EM, Roberti C, Mancini G, Pozzilli C, Bragoni M, Toni D. Spontaneous middle cerebral artery reperfusion in ischemic stroke: a follow-up study with transcranial Doppler. Stroke. 1995;26:430-433.
16. Burgin WS, Malkoff M, Demchuk AM, Felberg RA, Christou I, Grota JC, Alexandrov AV. Transcranial Doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke. Stroke. 2000;31:1128-1132.
17. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne M, Hennerici M. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
18. von Kummer R, Allen KL, Holle R, Bozzao L, Bastianello S, Manelfe C, Bluhmki E, Ringleb P, Meier DH, Hecke W. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology. 1997;205:327-333.
19. Pessin M, del Zoppo G, Estol C. Thrombolytic agents in the treatment of stroke. Clin Neuropharmacol. 1990;13:271-289.
20. Larrue V, von Kummer R, del Zoppo G, Bluhmki E. Hemorrhagic transformation in acute ischemic stroke. Stroke. 1997;28:957-960.
21. Lyden P, Brott T, Tilley B, Welch KMA, Mascha EJ, Levine S, Haley EC, Grotta J, Marler J, and the NINDS t-PA Stroke Study Group. Improved reliability of the NIH Stroke Scale using video training. Stroke. 1994;25:2220-2226.
22. Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-607.
23. Buchan AM, Barber PA, Newcommon NJ, Karbalai HG, Demchuk AM, Hoyte KM, Klein GM, Feasby TE. Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness. Neurology. 2000;54:679-684.
24. Larrue V, von Kummer R, Muller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke. 2001;32:438-441.
25. Schellinger PD, Jansen O, Fiebach JB, Heiland S, Steiner T, Swab S, Pohlers O, Ryssel H, Sartor K, Hacke W. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke. 2000;31:1318-1328.
26. Parsons MW, Barber PA, Chalk J, Darby DG, Rose S, Desmond PM, Gerraty RP, Tress BM, Wright PM, Donnan GA, Davis SM. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol. 2002;51:28-37.
27. 2 modulation on cortical intracellular acidosis. NADH redox state, and infarction in the ischemic penumbra. Stroke. 1999;30:160-170.
28. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, Tress BM, Davis SM. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002;52:20-28.
29. Els T, Klisch J, Orszagh M, Hetzel A, Schulte-Monting J, Schumacher M, Lucking CH. Hyperglycemia in patients with focal cerebral ischemia after intravenous thrombolysis: influence on clinical outcome and infarct size. Cerebrovasc Dis. 2002;13:89-94.
30. Kawai N, Keep RF, Benz AL. Hyperglycemia and the vascular effects of cerebral ischemia. Stroke. 1997;28:149-154.
31. Rezkalla RH, Kloner RA. No-reflow phenomenon. Circulation. 2002;105:656-662.
32. Li PA, Shuaib A, Miyashita H, He QP, Seisjo BK. Hyperglycemia enhances extracellular glutamate accumulation in rats subjected to forebrain ischemia. Stroke. 2000;31:183-192.
33. Koistinaho J, Pasonen S, Yrjanheikki J, Chan PH. Spreading depression-induced gene expression is regulated by plasma glucose. Stroke. 1999;30:114-119.
34. Puisinalli WA, Waldman S, Rawlinson D, Plum F. Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in rats. Neurology. 1982;32:1239-1246.
35. Dietrich WD, Alonso O, Busto R. Moderate hyperglycemia worsens acute blood-barrier injury after forebrain ischemia in rats. Stroke. 1993;24:111-116.